Campus Digest

School of Chinese Medicine hosts International Summit on Innovative Drug Discovery 

Friday, 3 November 2023

{{currentSlide}} / 4
Professor Jia Wei shares the success stories and remarkable achievements of SCM.
Professor Lyu Aiping, Vice President (Research and Development) (4th left); Professor Bian Zhaoxiang, Associate Vice-President (Chinese Medicine Development) (3rd left); Professor Jia Wei, Acting Dean of Chinese Medicine (5th left); Professor Zhang Ge, Associate Dean (Research) of Chinese Medicine (5th right); Professor Zhang Hongjie, Director of the Teaching and Research Division of SCM (4th right) at HKBU, together with the speakers and moderators of the talk with the theme “New Horizons in Deciphering the Ecological Construction and Investment for New Drug Discovery and Development”.
SCM representatives and the speakers and moderators of the talk with the theme “Strategy and Translational Practice of New Drug Discovery and Development in the New Era”.
SCM representatives and the speakers and moderators of the talk with the theme “Innovator Insights into New Drug Discovery and Development”.

The School of Chinese Medicine (SCM) organised the 5th International Summit on Innovative Drug Discovery on campus on 28 October. The event brought together leaders and scholars in the drug discovery field to share insights on policies concerning research and development of innovative drugs as well as paths and practical experience of innovative drug discovery.

In his welcoming address, Professor Alexander Wai, President and Vice-Chancellor of HKBU, emphasised the immense value of Chinese medicine, highlighting its potential to make substantial contributions to public health. He also shared the University’s latest achievements in scientific research and clinical studies, underscoring HKBU’s dedication to the advancement of health and drug discovery through a scientific and standardised approach.

Speaking at the event, Professor Jia Wei, Acting Dean of Chinese Medicine of HKBU, shared SCM’s success stories and remarkable achievements in translating research results into innovative solutions. He said that with a focus on translational research, SCM’s researchers have been exploring the mechanisms of human diseases and advancing the development of precision medicine and novel treatment options.

This Summit, held both in-person and online, carried the themes of “New Horizons in Deciphering the Ecological Construction and Investment for New Drug Discovery and Development”, “Strategy and Translational Practice of New Drug Discovery and Development in the New Era” and “Innovator Insights into New Drug Discovery and Development”. It featured 15 talks by officials from the National Medical Products Administration, pharmaceutical entrepreneurs and esteemed scholars from Mainland China, Hong Kong, Macau, and Australia, attracting approximately 500 attendees.